Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
Encompass Health Corp (EHC)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: EHC (4-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 63.5% | Avg. Invested days 125 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 5.0 | Stock Returns Performance 3.0 |
Profits based on simulation | Last Close 01/14/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.38B USD | Price to earnings Ratio 21.9 | 1Y Target Price 116.75 |
Price to earnings Ratio 21.9 | 1Y Target Price 116.75 | ||
Volume (30-day avg) 603650 | Beta 0.78 | 52 Weeks Range 69.21 - 104.36 | Updated Date 01/14/2025 |
52 Weeks Range 69.21 - 104.36 | Updated Date 01/14/2025 | ||
Dividends yield (FY) 0.73% | Basic EPS (TTM) 4.25 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 8.1% | Operating Margin (TTM) 15.48% |
Management Effectiveness
Return on Assets (TTM) 8.38% | Return on Equity (TTM) 22.92% |
Valuation
Trailing PE 21.9 | Forward PE 19.34 | Enterprise Value 11977077977 | Price to Sales(TTM) 1.8 |
Enterprise Value 11977077977 | Price to Sales(TTM) 1.8 | ||
Enterprise Value to Revenue 2.3 | Enterprise Value to EBITDA 10.47 | Shares Outstanding 100750000 | Shares Floating 99290693 |
Shares Outstanding 100750000 | Shares Floating 99290693 | ||
Percent Insiders 1.31 | Percent Institutions 98.56 |
AI Summary
Encompass Health Corp. (NYSE: EHC): A Deep Dive
Company Profile
History and Background:
- Founded in 1996 as HealthSouth Corporation, the company initially focused on inpatient rehabilitation services.
- In 2019, the company rebranded itself as Encompass Health and expanded into home health and hospice services.
- Today, Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with over 135 hospitals and 250 home health locations.
Core Business Areas:
- Inpatient Rehabilitation: Encompass Health provides inpatient rehabilitation services to patients recovering from strokes, brain injuries, spinal cord injuries, amputations, and other debilitating conditions.
- Home Health: Encompass Health provides home-based skilled nursing, physical therapy, occupational therapy, and speech therapy to patients recovering from illness or injury.
- Hospice: Encompass Health offers end-of-life care and support to patients and their families.
Leadership Team and Corporate Structure:
- Board of Directors: https://www.encompasshealth.com/investor-relations/corporate-governance/encompass-health-corporation-board-of-directors
- Executive Leadership Team: https://www.encompasshealth.com/about-us/leadership-team
- Corporate Structure: Encompass Health operates as a single business segment, providing inpatient rehabilitation, home health, and hospice services.
Top Products and Market Share:
- Inpatient Rehabilitation: Encompass Health holds the largest market share in the U.S. inpatient rehabilitation market, controlling approximately 33%.
- Home Health: Encompass Health is the fourth largest home health provider in the U.S. with a market share of approximately 4%.
- Hospice: Encompass Health is the sixth largest hospice provider in the U.S. with a market share of approximately 4%.
- Competitive Comparison: Encompass Health stands out in the industry for its diversified service offerings, which allows them to care for patients across the entire continuum of post-acute care.
Total Addressable Market
- The U.S. post-acute care market is estimated to be worth $170 billion, encompassing inpatient rehabilitation, home health, and hospice services.
- This market is expected to grow at a rate of 5% annually, driven by an aging population and rising prevalence of chronic diseases.
Financial Performance
Revenue: Q3 2023 revenue was $1.90 billion, representing a year-over-year increase of 4.6%.
Net Income: Q3 2023 net income was $137.2 million, compared to $139.6 million in Q3 2022.
Profit Margins: Gross profit margin in Q3 2023 was 15.8% and operating profit margin was 11.5%.
Earnings Per Share: Q3 2023 EPS was $1.03 compared to $1.01 in Q3 2022.
Financial Performance Comparison:
- Revenue has grown steadily over the past five years.
- Profit margins have remained stable.
- EPS has also grown steadily.
Cash Flow and Balance Sheet: Encompass Health has a healthy cash flow and balance sheet. The company has a low debt-to-equity ratio and is generating positive free cash flow.
Dividends and Shareholder Returns:
- Dividend History: Encompass Health has a history of paying dividends since 2018.
- Current dividend yield is approximately 1.4%.
- Payout ratio is approximately 30%.
- Shareholder Returns: Over the past year, Encompass Health stock has returned 18.2%.
- Over the past five years, Encompass Health stock has returned 175.1%.
Growth Trajectory
- Historical Growth: Encompass Health has experienced strong historical growth.
- Revenue has grown at a compound annual growth rate of 10% over the past five years.
- EPS has grown at a compound annual growth rate of 15% over the past five years.
- Future Growth Projections: Encompass Health expects to continue to grow in the future.
- The company projects revenue growth of 5-7% in 2023.
- The company also expects to expand its margins and grow its EPS.
- Recent Growth Initiatives: Encompass Health is making several investments to drive future growth.
- The company is expanding its inpatient rehabilitation network.
- The company is investing in technology to improve patient care and efficiency.
Market Dynamics
- Industry Trends: The post-acute care industry is expected to continue to grow in the future. This growth will be driven by an aging population and rising prevalence of chronic diseases.
- Demand-Supply: The supply of post-acute care services is expected to meet demand in the coming years.
- Technological Advancements: Technology is playing an increasing role in the post-acute care industry. Encompass Health is investing in technology to improve patient care and efficiency.
Competitors
Major competitors:
- Kindred Healthcare (KND) - Market Share: 17%
- Select Medical (SEM) - Market Share: 14%
- Amedisys (AMED) - Market Share: 5%
Competitive Advantages: Encompass Health has several competitive advantages, including:
- Largest market share
- Diversified service offerings
- Strong financial position
- Investment in technology
Potential Challenges and Opportunities
Key Challenges:
- Supply Chain Issues: Encompass Health is facing some supply chain issues, which could impact the cost of care.
- Technological Changes: The post-acute care industry is constantly evolving, and Encompass Health needs to keep up with the latest technological advancements.
- Competitive Pressures: Encompass Health faces competition from other large post-acute care providers.
Opportunities:
- **New Market
About NVIDIA Corporation
Exchange NYSE | Headquaters Birmingham, AL, United States | ||
IPO Launch date 1986-09-30 | CEO, President & Director Mr. Mark J. Tarr | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 27481 | Website https://www.encompasshealth.com |
Full time employees 27481 | Website https://www.encompasshealth.com |
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.